Faculty Publications

Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-alpha or the combination of temsirolimus plus interferon-alpha

De Souza P, Maart K, Laurell A, Hawkins RE, Berkenblit A, Galand L, Thiele A, Strahs A, Feingold J, Hudes G

Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-alpha or the combination of temsirolimus plus interferon-alpha

EJC Supplements. 2007 Sep;5(4):282-3.

Abstract

Last updated on Saturday, November 21, 2009